Gc-1 Sobetirome | Gc-1 Sobetirome 1500 mcg
Gc-1 Sobetirome, Gc-1 Sobetirome 1500 mcg. A synthetic thyromimetic substance called GC-1 Sobetirome (1500 mcg) is intended to specifically activate the thyroid hormone receptor beta (TRβ). It is a viable option for studies on metabolic disorders, cholesterol management, and neurodegenerative diseases since it does not overstimulate thyroid hormone receptor alpha (TRα), unlike natural thyroid hormones.
- A selective agonist of the thyroid hormone receptor beta (TRβ) is sobetirome (GC-1).
- It was designed to replicate the advantageous metabolic effects of thyroid hormone without causing undesirable bone-related or cardiovascular adverse effects linked to TRα activation.
- This structural analog of triiodothyronine (T3) is often referred to as QRX-431.
Gc-1 Sobetirome | Characteristics
- Chemical Class: Synthetic thyromimetic agent.
- Selectivity: Strong affinity for TRβ, minimal activity at TRα.
- Formulation: Research frequently mentions 1500 mcg dosages in oral pill form.
- Mechanism: Increases mitochondrial activity, energy expenditure, and lipid metabolism.
- Half-Life: Longer than natural thyroid hormones, allowing sustained activity.
Gc-1 Sobetirome | Impacts
- Cholesterol Reduction: By activating TRβ in the liver, it lowers triglycerides and LDL cholesterol.
- Fat Metabolism: Encourages the oxidation of fatty acids and decreases the buildup of fat.
- Energy Regulation: Raises the basal metabolic rate without causing the heart to beat too quickly.
- Neuroprotection: Examined for possible advantages in demyelinating conditions such as multiple sclerosis.
- Weight management: Promotes increased metabolic efficiency and fat removal.
- Liver Health: Because it lowers cholesterol, it has been studied for non-alcoholic fatty liver disease (NAFLD).
Advantages
- Cardiovascular Safety: By protecting TRα, sobetirome prevents tachycardia and arrhythmias, in contrast to T₃.
- Metabolic Disorders: Possible treatment for metabolic syndrome, obesity, and hyperlipidemia.
- Remyelination in multiple sclerosis and other CNS illnesses has been studied in neurodegenerative research.
- Easy Dosing: Standardized administration in research is made possible by the capsule form (1500 mcg).
- Longevity Potential: It may promote healthier aging by enhancing mitochondrial and lipid metabolism.
Comparison: Sobetirome vs. Natural Thyroid Hormones
| Feature | Sobetirome (GC-1) | Natural T3/T4 |
|---|---|---|
| Receptor Selectivity | TRβ selective | TRα + TRβ |
| Cardiac Effects | Minimal | Tachycardia, arrhythmias |
| Metabolic Effects | Strong lipid-lowering, fat oxidation | General metabolic regulation |
| Neuro Effects | Potential remyelination | Limited |
| Safety Profile | Designed to reduce side effects | Higher risk of systemic effects |
Synopsis
The selective thyroid hormone receptor beta agonist sobetirome GC-11500 mcg has been investigated for its potential to promote neuroprotection, improve fat metabolism, and reduce cholesterol. It is a safer option for metabolic and neurodegenerative studies because it does not overstimulate the heart or bones like natural thyroid hormones do.




Reviews
There are no reviews yet.